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Adenoviruses (AdVs) are icosahedral viruses with double-stranded DNA (dsDNA)
genomes. Genome packaging in AdV is thought to be similar to that seen in dsDNA
containing icosahedral bacteriophages and herpesviruses. Specific recognition of the
AdV genome is mediated by a packaging domain located close to the left end of the viral
genome and is mediated by the viral packaging machinery. Our understanding of the
role of various components of the viral packaging machinery in AdV genome packaging
has greatly advanced in recent years. Characterization of empty capsids assembled in
the absence of one or more components involved in packaging, identification of the
unique vertex, and demonstration of the role of IVa2, the putative packaging ATPase,
in genome packaging have provided compelling evidence that AdVs follow a sequential
assembly pathway. This review provides a detailed discussion on the functions of the
various viral and cellular factors involved in AdV genome packaging. We conclude by
briefly discussing the roles of the empty capsids, assembly intermediates, scaffolding
proteins, portal vertex and DNA encapsidating enzymes in AdV assembly and packaging.
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INTRODUCTION
Adenoviruses (AdVs) are icosahedral nonenveloped DNA viruses belonging to the family
Adenoviridae and are ∼90 nm in diameter. They are known to infect a wide range of species.
Some of the AdVs can cause life threatening disease in immunocompromised hosts. Human
AdVs (HAdVs) constitute more than 70 types (Hage et al., 2015), which are sub-classified into
species A through G based on genome sequence, agglutination properties, immune cross-reactivity
and genome organization. They are known to cause respiratory infections, conjunctivitis and
gastroenteritis in normal individuals (Russell, 2009). The HAdVs belonging to species B and C
are well characterized among HAdVs.
In the last three decades, research on AdVs has focused extensively on their development as gene
delivery vectors. Understanding of the AdV assembly process is important for the development
of improved drug delivery vehicles and vectors for gene delivery, for studying the assembly and
packaging of other animal viruses or macromolecular complexes, and for better understanding
of virus evolution. Additionally, the AdV assembly pathway can lead to the discovery of novel
anti-viral targets and nanotechnological tools.
AdV has a pseudo T = 25 icosahedral capsid enclosing a linear dsDNA genome varying in
size (26–45Kbp) depending on the AdV serotype. The HAdV serotype 5 (HAdV-C5) capsid is
composed of a total of 14 proteins (Table 1; Reddy and Nemerow, 2014). The hexon (protein
II of 109 kDa in size), penton base (protein III of 63.3 kDa in size) and fiber (protein IV
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TABLE 1 | Protein composition of AdV empty and mature capsids.
AdV protein Presence in
empty or mature
capsids
Copy
number of
monomer
Location Function/s References
II (Hexon) Both 720 Capsid (exterior) Structure Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014; Reddy and
Nemerow, 2014
III (Penton base) Both 60 Vertex (exterior) Structure, Entry Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014
IIIa Both 68 ± 2 Capsid (exterior)?
Vertex (Interior)?
Cement Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014; Reddy and
Nemerow, 2014
Fiber Both 36 Vertex (exterior) Structure, Entry Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014
V Mature 157 Core Core
condensation
Takahashi et al., 2006; Liu et al., 2010;
Reddy et al., 2010; Benevento et al.,
2014; Perez-Berna et al., 2015
VI Both 342 ± 4 Vertex (Interior)? Cement, Entry,
Trafficking, early
gene expression
Wiethoff et al., 2005; Liu et al., 2010;
Reddy et al., 2010; Wodrich et al., 2010;
Moyer et al., 2011; Graziano et al., 2013;
Schreiner and Wodrich, 2013; Benevento
et al., 2014; Luisoni et al., 2015
VII Mature 527 ± 44 Core Core
condensation
Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014; Perez-Berna et al.,
2015
VIII Both 128 ± 3 Capsid (interior) Cement Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014
IX Both 247 ± 2 Capsid (exterior) Cement Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014
TP Both 2 Core DNA replication Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014
mu Mature 290 ± 18 Core Core
condensation
Liu et al., 2010; Reddy et al., 2010;
Benevento et al., 2014; Perez-Berna et al.,
2015
AVP Both 15 ± 5 Core Maturation Rancourt et al., 1995; Liu et al., 2010;
Reddy et al., 2010; Benevento et al.,
2014; Perez-Berna et al., 2014, 2015;
Condezo et al., 2015
IVa2 Both 7 ± 1 Unique vertex Packaging Christensen et al., 2008; Ostapchuk and
Hearing, 2008; Ahi et al., 2013
L4 33K Empty ? Unique vertex Packaging Christensen et al., 2008; Ostapchuk and
Hearing, 2008; Ahi et al., 2013, 2015; Wu
et al., 2013
L4 22K Empty ? Unique vertex (?) Packaging Ostapchuk et al., 2006; Wu et al., 2012;
Guimet and Hearing, 2013
L1 52/55K Empty 50 Capsid (interior) Packaging,
Genome retaining?
Perez-Berna et al., 2014
72K (DBP) Both ? Unique vertex Capsid assembly,
DNA replication
Nicolas et al., 1983; Ahi et al., 2013
Copy number of monomer, location, and function of each protein are indicated. The question mark sign (?) in the copy number column indicates that the information is unknown. The
question mark (?) in the location and function column indicates the predicted location and function.
of 61.9 kDa in size) are referred to as the major capsid proteins.
The 240 trimers of hexon represent the most abundant capsid
component. Pentons occupy the 12 vertices of the icosahedron.
Each penton is composed of a trimeric penton base with a
protruding trimeric fiber. The minor capsid components, protein
IIIa (63.5 kDa), VIII (15.4 kDa), and IX (14.4 kDa), function
primarily as cement proteins by connecting the major structural
units with each other and the viral core (Vellinga et al., 2005;
Russell, 2009). Protein VI, in addition to serving as a cement
protein, also plays important roles in virion maturation, entry,
trafficking and early gene expression (Wiethoff et al., 2005;
Wodrich et al., 2010; Moyer et al., 2011; Graziano et al., 2013;
Schreiner and Wodrich, 2013; Luisoni et al., 2015). The viral
core contains the dsDNA genome (35,938 Kbp in HAdV-C5)
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FIGURE 1 | Transcription map of HAdV-C5 genome. Viral genome is shown in blue. The early regions (E1, E2, E3, and E4) and the late regions (L1, L2, L3, L4,
and L5) are shown in gray. Proteins expressed from various regions are indicated above or below the region. Factors involved in AdV packaging are shown in red. The
map is not drawn to scale.
associated with four proteins: V (41.6 kDa), VII (19.4 kDa), µ
(4 kDa), and terminal protein (TP) [55 kDa], in addition to the
viral protease (23 kDa) (Everitt et al., 1973; Rux and Burnett,
2004; Vellinga et al., 2005; Perez-Berna et al., 2015). IVa2, L4 33K,
L4 22K, E2 72K, and L1 52/55K proteins are involved in capsid
assembly and/or genome packaging (Nicolas et al., 1983; Roovers
et al., 1990; Christensen et al., 2008; Wohl and Hearing, 2008;
Wu et al., 2012, 2013; Perez-Berna et al., 2014; Ahi et al., 2015;
Condezo et al., 2015). The viral proteins with a role in genome
packaging are depicted in the transcription map of HAdV-C5
(Figure 1).
Viruses may follow one of the two possible assembly pathways
(Casjens, 1997). (1) Concomitant assembly: the capsids are
assembled by sequential addition of the capsomers around the
viral genome. This kind of assembly is seen in helical viruses,
for example the tobacco mosaic virus, in spherical retroviruses
and even in some icosahedral viruses, for example SV40 (Kawano
et al., 2006). (2) Sequential assembly: The majority of viruses
with icosahedral capsids first assemble the empty capsids or
procapsids through the interaction of one or more structural
units followed by the incorporation or “packaging” of the
viral genome into the preformed capsids (Casjens, 1997). AdV
assembly is thought to proceed along the sequential pathway
that includes the following steps (Figure 2): (1) Assembly of
the hexon and penton capsomers followed by the assembly of
empty capsids, which also involves the minor capsid proteins
and the non-structural proteins; (2) Specific recognition of
the viral genome by packaging proteins; (3) Insertion of the
viral genome into empty capsids, presumably through a portal
located at a unique vertex, and release of scaffolding and some
of the packaging proteins; and (4) Cleavage of the precursor
proteins by the viral protease, enabling final maturation of
viral particles (D’Halluin, 1995; Ostapchuk and Hearing, 2003b,
2005). The assembly of AdV hexon trimers is dependent on
a virus-encoded chaperone-like L4 100K protein (Cepko and
Sharp, 1982; Hong et al., 2005). In addition to empty and
mature virus particles, light and heavy intermediate particles
are also detected in AdV infected cells (Edvardsson et al., 1976,
1978; D’Halluin et al., 1978a,b). The light intermediate particles
are associated with increasing lengths of DNA derived from
the left end of the viral genome (Daniell, 1976; Daniell and
Mullenbach, 1978; D’Halluin et al., 1978b), and may represent
capsids in the process of packaging (Figure 2, step 3). The
heavy intermediate particles possibly represent particles after
packaging, but before cleavage of precursor proteins by viral
protease (Figure 2, step 4).
ADV PACKAGING DOMAIN
Selective packaging of the viral genome by capsids poses an
interesting puzzle for the completion of the viral life cycle.
The viral genome must be recognized selectively by the viral
packaging complex for specific incorporation into the capsid. The
AdV genome carries a unique sequence, called the packaging
domain (PD), comprising a series of AT-rich repeats, located
between the left inverted terminal repeat (ITR) and the E1A
transcription start site (Hammarskjöld and Winberg, 1980;
Kosturko et al., 1982). The PD of HAdV-C5 (Figure 3) is
extensively characterized and is located between nucleotides 220
and 400 (Grable and Hearing, 1990, 1992; Tyler et al., 2007). The
observation that the incomplete AdV particles are associated with
varying lengths of DNA fragments representing the left end of the
genome suggested polar packaging of the AdV genome starting
from the left end (Daniell, 1976). The location of the HAdV-C5
PD has some flexibility since it can work efficiently if placed close
to the right end of the genome as long as it is within 600 bp from
the ITR, suggesting that the TP and/or the ITRs may play some
role in genome packaging (Hearing et al., 1987). Similar to AdVs,
the bacteriophage phi29 and PRD1 genomes contain ITRs and
TP covalently linked to the 5′ end of the genomes (Grimes and
Anderson, 1989; Savilahti and Bamford, 1993). The TP of phi29
potentiates genome packaging, suggesting a similar mechanism
in AdVs. However, a later in vivo (refers to cell culture in the
context of this review) study showed that the removal of TPs
and ITRs did not significantly decrease the efficiency of genome
packaging indicating that the AdV genome packaging process
may differ from that of phi29 in mechanistic details (Ostapchuk
and Hearing, 2003a). Presumably, the distance of the PD from
the left end governs the orientation of the genome with respect to
the portal. If the location is too far from the left end, it may pose
a structural constraint that prevents “threading” of the genome
through the portal.
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FIGURE 2 | Predicted model of AdV assembly and packaging. Step 1: Capsid assembly: Empty capsids are assembled from hexon trimers and pentons, along
with the minor capsid proteins (pIIIa, pVI, pVIII, IX, protease and portal) and the non-structural proteins (L1 52/55K and the scaffolding protein). Step 2: Genome
recognition: Packaging proteins IVa2, L4 33K, L1 52/55K, and L4 22K bind to the packaging domain located close to the left end of the genome. The genome is
associated with pTP at each end. Step 3: Packaging: The genome is inserted into the empty capsids through an unknown portal located at the unique vertex by the
action of IVa2, L4 22K, and L4 33K. The core proteins V, VII and mu are incorporated into the empty capsids during or after genome incorporation. Step 4: Final
maturation: Scaffolding protein (not known), L4 22K and 33K are released during or after genome incorporation. The virus encoded protease cleaves its substrates
pIIIa, L1 52/55K, pVI, pVII, pVIII, mu and pTP, resulting in conformational changes in the capsid structure and maturation of the virus particle. pVI, precursor VI; pVII,
precursor VII; pVIII, precursor VIII; pTP, precursor terminal protein.?, indicates that the identity is not known. L and R indicate left and right ends of the viral genome,
respectively.
The HAdV-C5 PD consists of seven AT-rich repeats,
referred to as A-repeats, numbered A1-A7 from left to
right (Ostapchuk and Hearing, 2003a,b). The A-repeats are
“functionally redundant,” implying that all A-repeats are not
essential for efficient packaging. Some A-repeats are more
efficient in directing the genome packaging than others (Hearing
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et al., 1987; Grable andHearing, 1990, 1992; Schmid andHearing,
1997). Specifically, the A1, A2, A5, and A6 repeats are most
important and act in pairs of A1 and A2, and A5 and A6
(Schmid and Hearing, 1997). Sequence alignment suggested that
they share a bipartite consensus motif 5′-TTTGN8CG-3′ and
also revealed the presence of a 21 bp spacer between A1 and
A2, and between A5 and A6. The A3, A4, and A7 repeats
do not show significant homology to the bipartite consensus
mentioned above and are not absolutely required for packaging,
but may be important for optimal packaging efficiency (Grable
and Hearing, 1992; Schmid and Hearing, 1997). The sequence
of an 8 nucleotide (nt) spacer between TTTG and CG of the
consensus motif is not conserved, but the length is essential
for the function of the A-repeats, as increasing the spacing by
an additional 4 nt results in significant reduction in packaging
efficiency (Schmid and Hearing, 1997). The spacing of 21 bp,
which corresponds to two turns of the DNA helix, presumably
facilitates the binding of “transacting” factors, recognizing one
A-repeat pair on the same face of the helix. Precise nt spacing
may also be necessary for essential mutual interactions among
the factors that bind to the adjacent A-repeats. The conserved
consensus motif may also suggest the binding of the same
protein on different A-repeats. Evolution of the AdV PD with
redundant A-repeats may be a mechanism to ensure a highly
specific recognition of the viral genome by the viral or cellular
transacting factors that connect the genomewith an empty capsid
and set up a packaging initiation complex. Indeed, an AdV
genome carrying a single A-repeat has a significant defect in
packaging efficiency (Schmid and Hearing, 1998). A synthetic
PD consisting of multiple copies of a single A-repeat functions
efficiently, demonstrating functional redundancy of A-repeats
and establishing A-repeats as a minimal functional unit of the
AdV PD. (Schmid and Hearing, 1998).
The presence of transacting factors that bind to the PD
was initially suggested by in vivo competition experiments.
Co-transfection of a plasmid carrying PD sequences and the
HAdV genome caused remarkable reduction in final virus yield
without showing any significant differences in protein expression
and DNA replication (Grable and Hearing, 1992). Similarly, a
mutant HAdV-C5 carrying 20 copies of the A6-repeat competed
for packaging more effectively than a mutant with 16 copies
of the A6-repeat in a co-infection experiment (Schmid and
Hearing, 1998). These observations indicated that there is a
direct competition among the packaging sequences for essential
proteins that bind to the PD and mediate genome packaging.
Various studies have used the packaging repeats as probes to
discover novel proteins that interact with the PD. The transacting
factors that were shown to have a functional association with the
PD will be discussed further in the subsequent section.
Alignment of sequences from the left end of AdV serotypes
representing different species showed conservation of the
bipartite consensus motif of the HAdV-C5 PD, suggesting
a common DNA packaging mechanism. There are subtle
differences among the A-repeats of PDs of various AdV
serotypes. These differences possibly reflect variation in the DNA
binding specificities of packaging proteins, but are unlikely to
alter the packaging mechanism (Ostapchuk and Hearing, 2003b).
FIGURE 3 | Schematic depiction of the left end of HAdV-C5 genome.
The packaging domain of HAdV-C5 is located between 220 and 400bp of the
viral genome and consists of seven AT-rich repeats, referred to as A-repeats.
The terminal protein (TP) is covalently attached to the 5′-phosphate. The left
inverted terminal repeat (left ITR) extends from 1 to 103bp. Transcription from
the early region 1A (E1A) begins at 499 bp.
PROTEINS INVOLVED IN ADV DNA
PACKAGING
The precise dissection and characterization of AdV PD was the
first step toward the understanding of AdV packaging. A logical
next step was to identify various proteins that are involved in
this complex process. A simple and seemingly straightforward
approach was to detect the proteins that interact with the
PD sequences; however, the overlap of the E1A transcription
enhancer elements with the PD is a confounding factor (Bolwig
et al., 1992; Hatfield and Hearing, 1993). Proteins that bind to
this region may either act as transcriptional enhancer factors,
packaging factors or both. Characterization of the minimal
functional unit of the HAdV-C5 PD offered a simple approach
that led to the identification of both the viral and cellular proteins
that associate with the PD and could play an important role
in genome packaging (Table 2). Proteins that associate with the
PD include viral proteins: IVa2, L4 33K, L4 22K, L1 52/55K
and IIIa, and cellular proteins: chicken ovalbumin upstream
promoter transcription factor (COUP-TF), Oct-1 and CCAAT
displacement protein (CDP). The role of each of these proteins
in AdV packaging is discussed in the sections below.
Viral Proteins
Identification of viral proteins involved in AdV packaging relied
on DNA-protein electrophoretic mobility shift assay (EMSA)
of nuclear extracts of HAdV-C5-infected cells. These EMSA
experiments using a probe comprising A1 and A2 repeats of
PD, resulted in the identification of two specific complexes: x
(larger) and y (smaller) (Zhang and Imperiale, 2000). AdV IVa2
protein, which binds to the downstream element (DE) of the
major late promoter, was also identified in complexes x and y.
The interaction of IVa2 with the CG motif of A-repeats was
essential for the formation of both x and y complexes, whereas
the formation of complex y required the binding of IVa2 and an
unknown factor of viral origin or virus-induced cellular protein
at the TTTGmotif of A-repeats (Zhang and Imperiale, 2000). The
unknown factor was identified later as the AdV L4 22K protein
(Ostapchuk et al., 2006). Ostapchuk et al. provided a more
detailed analysis of the infected cell-specific complexes through
mutational analysis of the A1 and A2 repeats. Interestingly,
instead of two, they reported three complexes, with complexes 1
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TABLE 2 | Known AdV packaging factors.
Packaging factor Bind to PD Interaction with other factors Role in serotype specificity References
In vivo In vitro
IVa2 Yes Yes L1 52/55K, L4 33K No Zhang and Imperiale, 2000; Tyler et al., 2007
L4 33K Yes ? IVa2 ? Ali et al., 2007; Ahi et al., 2013, 2015
L4 22K Yes Yes ? No Ewing et al., 2007; Wohl and Hearing, 2008; Wu
et al., 2012
L1 52/55K Yes No IVa2, IIIa Yes Gustin et al., 1996; Perez-Romero et al., 2005; Wohl
and Hearing, 2008; Ma and Hearing, 2011
IIIa Yes ? L1 52/55K Yes Ma and Hearing, 2011
Question mark indicates “not known”.
and 2 being the same as complexes y and x, respectively (Table 3).
Introducing mutations in the conserved TTTG and CG motifs
of A1 and A2 repeats defined the sequences required for the
formation of these complexes. Removal of the CG motif of the
A1 repeat inhibited the formation of all three complexes, whereas
a mutation in the TTTG motif of the A2 repeat prevented the
formation of complex 2. The CG motif of the A2 repeat was
shown to be required for the formation of complex 3. These
results suggested that AdV IVa2 protein nucleates the formation
of a complex on the packaging repeats due to an initial interaction
with the CG motif of one of the A-repeats in the PD followed
by an interaction with the TTTG motif of a nearby A-repeat.
Interaction with the TTTG motif also required the presence of
L4 22K protein (Ostapchuk et al., 2006). It is followed by addition
of another IVa2 molecule to the complex through an interaction
with the CG motif of a second A-repeat. The formation of
various complexes in vitro correlates with growth properties of
the mutant viruses harboring double copies of A1 and A2 repeats
mutated at the TTTG and/or CGmotif/s. The interaction of IVa2
with the PD in vivo was also demonstrated by co-purification of
the PD and IVa2 with an anti-IVa2 antibody (Ostapchuk et al.,
2006). Dynamics of IVa2 and the PD interactions were further
characterized using purified IVa2 and 42–45 bp overlapping PD
probes (Tyler et al., 2007). In agreement with the previous results,
IVa2 demonstrated the highest affinity with a probe containing
A1 and A2 repeats, followed by A2, A4-A5, A5-A7, and A3
repeats. Mutations in the CG motif, but not in the TTTG motif
of the A1 repeat, disrupted IVa2 binding to the probe, reaffirming
the earlier proposition that IVa2 nucleates the formation of
protein complexes on the PD by binding to the CG motif.
Additionally, purified IVa2 showed a very high affinity to the
full-length PD producing several super-shifted complexes.
The 22K protein shares the N-terminal 105 amino acids with
the L4 33K protein which plays an important role in capsid
assembly and/or DNA packaging, thus raising the possibility
that either 33K or 22K could be present in complex 2. The
complexes 2 and 3 were detected by EMSA when nuclear extracts
of cells expressing 22K and IVa2 were used with A1 and A2
repeats. Further support for the earlier finding that 22K is the
unknown viral factor in complex x came from EMSA using
purified 22K and IVa2 proteins and the packaging repeats (Ewing
et al., 2007). In the absence of IVa2, purified 22K binds to
the A1-A2 probe at very high concentration (>200 nM) and
TABLE 3 | Composition of complexes detected by EMSA following virus
infection or transient expression of IVa2 and L4 22K using a probe
comprising A1 and A2 repeats (Ostapchuk et al., 2005, 2006).
Complex Components Binding site
1 (or y) IVa2 CG motif of A1 repeat
2 (or x) IVa2 + L4 22K IVa2: CG motif of A1 repeat L4 22K: TTTG motif
of A2 repeat
3 IVa2 + L4 22K Complex 2 + additional IVa2: CG of A2 repeat
Complex 1 and 2 are the same as complex y and x (Zhang and Imperiale, 2000),
respectively.
this binding is not affected by mutations in the TTTG motif,
suggesting that the binding is non-specific. However, in the
presence of IVa2 at its half-maximal binding concentration, 22K
binds to the A1-A2 probe at very low concentrations (0.3–8 nM),
resulting in formation of two complexes migrating slower than
the complex detected when IVa2 alone binds to the A1-A2 probe.
Further, as reported earlier, mutations in the TTTG or CGmotifs
abolished the slower migrating or all complexes, respectively.
These experiments with the purified proteins confirmed that
complex 1 contained IVa2 only, whereas complexes 2 and 3
contained IVa2 and 22K (Ewing et al., 2007). Later studies showed
that the 33K protein also interacts with the PD (Ali et al., 2007;
Ahi et al., 2015). 33K interacts with the A1 and A2 repeats (Ali
et al., 2007) in the presence of IVa2 and this interaction results in
the formation of two complexes similar to those reported earlier.
In contrast, a study by Wu et al. (2013) showed that 33K does
not preferentially bind to the PD. The reason for this discrepancy
regarding the interaction of 33K with the PD is not clear. Given
that 22K and 33K proteins share the N-terminal 100 amino acids,
it is possible that both 22K and 33K interact with the packaging
repeats in the presence of IVa2 and play an overlapping role.
IVa2
The AdV IVa2 gene is located between 11.3 and 16 map units
of the HAdV-C5 genome. Transcription of the IVa2 gene occurs
on the lower or anti-sense strand of the AdV genome from its
own promotor (Binger and Flint, 1984; Winter and D’Halluin,
1991). IVa2 contains both a nuclear and nucleolar targeting
signals (Figure 4). Consequently, the protein is targeted to the
nucleolus in virus-infected cells (Lutz et al., 1996) and exists in
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FIGURE 4 | Known functional domains of IVa2 protein. Known functional
domains of HAdV-C5 IVa2 protein (1–449 residues) are depicted. The locations
of the nucleolar localization signal (NuLS), Walker A motif (A), Walker B motif
(B), and nuclear localization signal (NLS) are shown. Dotted arrows (79–98,
and 421–449) indicate the regions that are part of the bipartite DNA binding
domain.
an unprocessed form in the mature virions as well as in the
light and heavy assembly intermediates (Winter and D’Halluin,
1991). IVa2 expressionwas detected as early as 12 h post-infection
and continued to increase until 24 h post-infection. Expression
was found to be dependent on cellular but not on viral DNA
replication (Winter and D’Halluin, 1991; Lutz and Kedinger,
1996).
IVa2 is a multi-functional protein involved in various stages
of the viral life cycle. Initial studies identified IVa2 as a
transcriptional activator of the AdV major late promoter (MLP).
IVa2 is a trans-acting factor and stimulates late gene transcription
through its interaction with the downstream control region of
MLP, which is composed of three regions, DE1, DE2a, and
DE2b (Lutz and Kedinger, 1996). Striking homology between DE
and PD was an impetus to examine the role of IVa2 in AdV
DNA packaging (Lutz and Kedinger, 1996). Secondary structure
analysis of IVa2 suggested that the DNA-binding domain of IVa2
consists of two parts, one closer to the N-terminus and the
other toward the C-terminus, each contributing an amphipathic
helix (Figure 4). The two amphipathic helices could assemble
into a DNA-binding domain with the hydrophobic faces buried
inside (Lutz and Kedinger, 1996). A recent study demonstrated
the importance of the amphipathic helix at the C-terminus of
IVa2 by deleting 10 amino acids. The chromatographic profile
and a partial digestion with chymotrypsin and trypsin suggested
that the deletion does not affect the tertiary structure of IVa2.
However, the mutant failed to interact with the AdV PD, and
therefore, could not support genome packaging (Christensen
et al., 2012).
Initially, IVa2 was thought to play an important role in
capsid assembly (Zhang and Imperiale, 2003). However, such
a role was later ruled out since AdV mutants lacking IVa2
resulted in assembly of empty capsids, thereby reinforcing the
role of IVa2 as a packaging ATPase (Ostapchuk et al., 2011).
Several observations point toward the importance of IVa2 in
AdV packaging. IVa2 interacts with the PD sequences, both
in vivo (Zhang and Imperiale, 2000; Ostapchuk et al., 2005;
Perez-Romero et al., 2005) and in vitro (Zhang and Imperiale,
2000; Tyler et al., 2007). Given the importance of the PD in
genome packaging, it would not be surprising to find that IVa2
is an important packaging factor. IVa2 has been shown by
immunogold labeling to be located at a single site on capsids
(Christensen et al., 2008; Ahi et al., 2013). Copy number of
a protein located at a single vertex is expected to be low.
Based on the results of western blotting, metabolic labeling and
quantitative mass spectrometry, the copy number of IVa2 was
found to be six to eight molecules per virus particle (Christensen
et al., 2008). The portal, one of the essential components of
the genome packaging machinery, forms the central channel for
passage of the genome during packaging, and is located at a
unique vertex. The portal is essential for capsid assembly and is
invariably present on the capsid as a dodecameric ring structure
(Simpson et al., 2000; Orlova et al., 2003; Trus et al., 2004; Doan
and Dokland, 2007). The presence of IVa2 on a unique vertex
suggested that it may serve as the AdV portal. However, the
low copy number of IVa2 on each virion and assembly of empty
capsids in its absence suggested that IVa2 cannot function as a
portal. If the AdV portal were to consist of only IVa2, the central
pore would not be large enough for passage of the genome. It
is possible that IVa2 in conjunction with another protein may
constitute the portal; however, all portals known to date consist
of a single protein. Therefore, we anticipate that the yet to be
identified AdV portal will have key features similar to the known
portals.
Studies with bacteriophages have shown that a motor protein
is required to force the viral genome into a pre-formed capsid
through the portal (Rao and Feiss, 2008). Most often, the
motor protein is an ATPase, which utilizes the chemical energy
of phosphodiester bonds to package the genome. Sequence
analysis of AdV IVa2 revealed the presence of the Walker A
and Walker B motifs, a characteristic feature of ATPases in
the ABC and AAA+ families. (Figure 4). The Walker motifs
in IVa2 are highly conserved among all AdVs, whereas the
other parts of IVa2 are variable. Secondary structure predictions
suggest that DNA packaging ATPases of phages and AdV IVa2
belong to the additional strand catalytic E (ASCE) class of
ATPases although there are certain differences suggesting that
they probably evolved independently (Burroughs et al., 2007).
Changing a single residue from lysine to arginine or alanine
within the Walker A motif was not tolerated, and thus, the
mutant AdV genome was unable to generate infectious virus
particles (Pardo-Mateos and Young, 2004). The lysine residue is
critical for binding to ATP, and therefore, is important for the
action of ATPases carrying the Walker motifs. Using purified
IVa2 protein, it was shown that the integrity of Walker A and B
motifs is important for ATP binding activity of IVa2 (Ostapchuk
and Hearing, 2008). Additionally, HAdV-C5 genomes harboring
IVa2 mutations in the ATPase domain failed to rescue an
infectious virus, but instead resulted in accumulation of empty
capsids, signifying that the block was at the DNA packaging
step (Ostapchuk et al., 2011). It is conceivable that the ATPase
function of an ATPase is activated only when this function
is required. Therefore, the ATPase function of IVa2 would be
initiated only during active genome packaging. Based on this
hypothesis, we demonstrated that the ATPase function of IVa2
is activated in the presence of viral genome and L4 33K, another
essential packaging factor (Ahi et al., 2015). This finding suggests
that IVa2 serves as a motor protein for AdV DNA packaging,
providing energy for pushing the genome into the capsid by ATP
hydrolysis.
Apart from the full-length IVa2 which is approximately 50
kDa, a truncated isoform of roughly 40 kDa also exists in
virus-infected cells, possibly due to translation initiation from
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methionine at position 75 (Pardo-Mateos and Young, 2004). In
the absence of the full-length IVa2, the 40 kDa IVa2 produced
two complexes in EMSA with the A1-A2 probe. Another study
using a purified preparation of 40 kDa IVa2 showed that it has
high affinity for binding to the A1-A2 repeats (Yang et al., 2009).
Taken together, the ability of 40 kDa IVa2 to bind to the packaging
sequences and the viability of mutant viruses expressing 40 kDa
IVa2 indicates that the 40 kDa isoform is able to perform the
packaging function.
L4 33K and 22K Proteins
The AdV 33K protein is expressed from the L4 region of the
major late transcription unit (MLTU). The predicted molecular
weight of 33K is 24.9 kDa; however, the relative molecular weight
was estimated to be around 39 kDa by SDS-PAGE (Oosterom-
Dragon and Anderson, 1983). This discrepancy between the
predicted and the observed molecular weight of 33K is mainly
due to the high proline and glutamic acid residue content, hyper-
phosphorylation and possible glycosylation of the 33K (Cauthen
and Spindler, 1996). In infected cells, 33K localizes exclusively
to the nucleus and organizes into unique granular structures
(Gambke and Deppert, 1981).
Expression of 33K during the late phase suggested that it may
play a role in upregulation of transcription from the MLTU and
suppression of transcription from the early regions. Contrary to
this hypothesis, a mutant virus (v33K.1) with a stop codon at
position 20 of the 33K orf did not show any significant reduction
in early or late gene expression or viral DNA replication, but
had a 7-fold decrease in virus yield (Fessler and Young, 1999).
The reduced virus yield was accounted for by a decrease in
intermediate and mature virus particles. A stop codon at position
138 of the 33K orf did not significantly affect early or late gene
expression, except that of proteins IIIa, and pVI (Wu et al., 2013).
As observed by Fessler and Young, the 33K mutant described
by Wu et al had a reduced yield of intermediate particles and
completely fails to package the viral genome. The reduced yield
of intermediate particles by 33K mutants despite lack of effect on
late gene expression suggests a role of 33K in capsid assembly.
In another study, deletion of 47 amino acid residues from the C-
terminus of 33K completely abolished capsid assembly (Finnen
et al., 2001). Thus, the studies by Fessler and Young, Wu et
al and Finnen et al suggest a role of 33K in capsid assembly.
However, the complete block in genome packaging in absence of
33K observed by Wu et al suggest that 33K is also important for
genome packaging.
Evidence for a role of 33K in capsid assembly also comes from
a study on bovine AdV serotype 3 (BAdV3). A homolog of the
33K gene is predicted in all AdV genomes (Vrati et al., 1995).
Three distinct isoforms of the 33K protein, which may represent
alternative splice variants, were detected in BAdV3-infected cells
(Kulshreshtha et al., 2004). A stop codon at position 7 in the
33K orf resulted in a severe defect in genome packaging, but did
not affect capsid assembly; however, a stop codon at position 97
resulted in complete loss of capsid assembly. These results are
similar to those observed with HAdV-C5 33K mutants. A stop
codon near the start of the orf may not prevent the expression of a
smaller 33K isoform which may be sufficient for capsid assembly,
but may not be fully active in performing its function in DNA
packaging, thus resulting in accumulation of empty capsids and
reduced mature virus yield. A stop codon further downstream
in the 33K orf might block expression of all isoforms, thereby
proving lethal due to a block in capsid assembly and implying
a role of the C-terminal domain of 33K in capsid assembly.
Collectively, these findings suggest that 33K has two functional
domains acting at two different steps in AdV morphogenesis: a
C-terminal domain functions during capsid assembly, and an N-
terminal domain plays a role in DNA packaging. BAdV3 33K
was shown to interact with the viral V and 100K proteins in
virus-infected cells (Kulshreshtha and Tikoo, 2008). Interaction
with 100K seems to be of significance with regard to hexon
trimerization and its import to the nucleus on the basis of the
following observations. In COS-7 cells, transiently expressed
100K failed to transport hexon into the nucleus, (Hong et al.,
2005) and the majority of hexon remained in the cytoplasm of
cells infected with a BAdV3 33K mutant (Kulshreshtha et al.,
2004). These observations point toward a possible role of 33K
in the nuclear transport of hexon. In insect cells, 100K alone
was sufficient for hexon trimerization and its transport to the
nucleus suggesting the presence of an unknown factor in the
insect cells but not in COS-7 cells. Therefore, it is possible that
33K acts as a bridge between hexon trimerization and capsid
assembly. Further experiments are warranted to explore this
hypothesis.
Proteins that participate in genome packaging assemble at
the “portal complex” which acts as a conduit for genome
translocation during packaging. Thus, the constituting proteins
of a portal complex assemble into ring-like oligomers. Purified
HAdV-C5 33K has been demonstrated to form ring-like
oligomers with a central channel (Ahi et al., 2015). In addition,
33K is located at a unique vertex on virus particles, interacts
with IVa2 and stimulates its ATPase function (Ahi et al., 2013,
2015). These findings indicate that the function of 33K in genome
packaging may be similar to that of the “small terminases” of
bacteriophages (Roy et al., 2012; Sun et al., 2012).
22K is another AdV protein that plays a role in DNA
packaging (Ostapchuk et al., 2006). In HAdV-C5, the orfs of 22K
and 33K begin at nt 26195. The 22K orf continues uninterrupted
until nt 26785. The 33K orf includes an intron between nts
26510 and 26713 and continues thereafter in a different reading
frame than 22K until nt 27086. As a result, 22K and 33K
share the N-terminal 105 amino acid residues, implying that
they may have a shared function. 22K was identified as a
constituent of the supershifted complexes using the packaging
repeats as probes in gel shift assays, and this interaction was
found to be dependent on the TTTG motif of the packaging
repeats. Efficient in vivo DNA packaging correlated with the
formation of these supershifted complexes on the packaging
repeats, suggesting the importance of 22K in DNA packaging
(Ostapchuk et al., 2005). Mutant AdV that does not express
22K assembles empty capsids, but they are defective in genome
packaging (Wu et al., 2012). The genome packaging function
of 22K is likely mediated by a conserved pair of cysteines
and histidines in its C-terminal region (Guimet and Hearing,
2013).
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L1 52/55K Protein
The L1 52/55K protein plays an important role in AdV
morphogenesis. The molecular weight of 48 kDa is predicted
from its amino acid sequence, but it migrates on SDS-PAGE
as a doublet at about 52 kDa. The two bands represent
differentially phosphorylated forms of 52/55K. Under non-
reducing conditions 52/55K forms higher molecular weight
species suggesting it forms homo-oligomers, possibly involving
disulfide linkages mediated by the Cys residue at position
24 (Hasson et al., 1989). 52/55K localizes to the nucleus,
concentrating at the nuclear periphery at sites distinct from
the viral DNA replication centers. HAdV-C5 mutants unable
to express 52/55K or carrying a two amino acid substitution
(EL334-335GP) fail to package DNA into empty capsids (Hasson
et al., 1989; Gustin and Imperiale, 1998). The capsids assembled
by these mutants were devoid of any viral DNA suggesting
that 52/55K plays an important role in the recognition and/or
incorporation of the viral DNA into empty capsids.
52/55K associates with the viral packaging sequences in virus-
infected cells (Perez-Romero et al., 2005). The interaction seems
to be mediated by another viral factor since the purified form
of 52/55K did not bind to the packaging sequences (Ostapchuk
et al., 2005; Perez-Romero et al., 2005). Interestingly, IVa2
interacts with 52/55K suggesting that 52/55K may bind to the
PD in the presence of IVa2 (Gustin et al., 1996). However,
the interaction of IVa2 and 52/55K with the PD was shown
to be independent of each other (Perez-Romero et al., 2005).
Interaction of 52/55K with IVa2 is mediated by the N-terminal
173 amino acids, whereas the genome packaging function lies in
the N-terminal 331 amino acids. Interestingly, the N-terminal
331 amino acids are also essential for interaction with the PD
in vivo, implying that 52/55K interaction with the packaging
sequences is essential for its function in genome packaging
(Perez-Romero et al., 2005). Empty capsids assembled by IVa2-
null HAdV-C5 mutants contain 52/55K in amounts comparable
to wild type virus, indicating that interaction with IVa2 is
not necessary to recruit 52/55K to empty capsids (Ostapchuk
et al., 2011). 52/55K also interacts with AdV IIIa, and this
interaction contributes to serotype-specific DNA packaging (Ma
and Hearing, 2011). Interestingly, 52/55K also binds to the
major core protein pVII (which also binds to IVa2) and to
the viral genome in a non-specific manner. The importance of
interactions of pVII with 52/55K or IVa2 is not clear; however,
given that pVII binds to unpackaged genome, its interactions
with the packagingmachinery will likely play a crucial role during
genome packaging (Zhang and Arcos, 2005).
Interestingly, a consensus recognition cleavage site for the
AdV 23K protease (AVP) is present in 52/55K (Webster
et al., 1989), and this site is conserved among various AdV
serotypes (Mangel and San Martin, 2014). A recent study
demonstrated that 52/55K is indeed a substrate for AVP (Perez-
Berna et al., 2014). 52/55K seems to be in an extensive network
of interactions with capsid proteins including hexon and penton
(shell), and pVIII and VII, in addition to interactions with
IIIa and IVa2 mentioned above. 52/55K is cleaved by AVP,
presumably concomitant with genome packaging, at a canonical
and multiple non-canonical consensus sequences into fragments
corresponding to molecular weights of 40, 34, 30, 27, and 18 kDa,
with 40 kDa being the predominant fragment. The cleavage of
52/55K by AVP, similar to its other substrates, is DNA-dependent,
and results in the loss of interaction of 52/55K with other capsid
proteins and the viral genome (Perez-Berna et al., 2014). Since
none of the fragments of 52/55K appear in the mature virus, they
are presumably ejected during or after packaging by an unknown
mechanism. Condezo et al. (2015) described two light assembly
intermediates, L2 and L3, of HAdV-C5 mutants with delayed
packaging. The maturation state of 52/55K was found to be
different in L2 and L3. L2 contains a larger fraction of full-length
52/55K than L3, whereas in L3, the fragments are more abundant.
In L2, 52/55K is located along the vertices, possibly in close
association with IVa2 at the portal vertex and with IIIa at other
vertices (Condezo et al., 2015). Given that 52/55K can interact
with the incoming genome due to its non-specific affinity to
DNA, it can be hypothesized that 52K/55K retains the incoming
genome inside the capsid shell, thus playing an important role in
organizing the packaged genome inside the shell. The observation
that L3 but not L2 is associated with the genome suggests that
the cleavage of 52/55K by AVP is a dynamic process that occurs
during or after genome packaging.
E2 72K Protein
E2 72K, also known as DNA-binding protein (DBP), interacts
with the packaging proteins IVa2 and 33K and is located at
a unique vertex of AdV (Christensen et al., 2008; Ahi et al.,
2013). Although the majority of studies on DBP have focused
primarily on its role in viral DNA replication, the studies from
our laboratory (Christensen et al., 2008; Ahi et al., 2013) and
another report (Nicolas et al., 1983) suggest that it may play an
important role in capsid assembly and/or genome packaging.
The DBP is expressed from the early region 2A (E2A) in
large amounts in virus-infected cells. It is essential for viral
DNA replication, although it also plays important roles in
determination of the host range, stability of viral mRNAs, and
host-cell transformation (Rice et al., 1987; Cleghon et al., 1989;
Harfst and Leppard, 1999). HAdV-C5 DBP contains two distinct
domains, 44K and 26K. The C-terminal 44K domain contains
amino acid residues from 174 to 529 and is sufficient for DNA
binding and in vitro DNA replication (Ariga et al., 1980). This
globular 44K fragment has a 17-amino acid residue extension
at the C-terminus that is essential for multimerization of DBP
on the displaced ssDNA during DNA replication (Tucker et al.,
1994; Dekker et al., 1997). The 26K N-terminal domain contains
several phosphorylation sites. Mutations affecting the C-terminal
domain block the role of DBP in DNA replication, but do
not affect its gene expression activity (Klein et al., 1979). Two
distinct classes of DBP can be recognized in virus-infected
cells by cell fractionation and immunofluorescence. The first
subclass is organized as globular structures inside the nucleus
and is primarily involved in active DNA replication. The second
subclass is more diffused within the nucleus (Voelkerding and
Klessig, 1986).
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Interestingly, a HAdV-C5 mutant with point mutations
affecting DBP is temperature-sensitive for capsid assembly in
HEK293 cells, but not in HeLa cells, suggesting that DBP
plays an essential role in virus assembly through interaction
with some host-specific factors. Importantly, at non-permissive
temperature, the mutant virus synthesizes the late viral structural
proteins in amounts similar to the wild-type virus, but does
not assemble capsids (Nicolas et al., 1983). Since AdV capsid
assembly and DNA replication occurs in distinct compartments
of the nucleus (Hasson et al., 1992), the diffusely staining subclass
of DBP may participate in capsid assembly. Currently, the role of
DBP in AdV capsid assembly or genome packaging is not clearly
understood and awaits further exploration.
Cellular Proteins
Nuclear extracts from AdV-infected or uninfected cells were
incubated with a probe consisting of the A5-7 repeats of the
AdV PD and analyzed initially by EMSA (Schmid and Hearing,
1998). This led to identification of two cellular proteins: P-
complex and COUP-TF. The binding of P-complex to various
A-repeats correlated with the packaging efficiency of the mutants
containing multimeric copies of different A-repeats. In contrast,
the binding of COUP-TF was strongest to the A-repeat with
weakest packaging efficiency. The findings suggested that P-
complex, but not COUP-TF, may be important for AdV genome
packaging (Erturk et al., 2003). This study also showed that a
third cellular protein, Oct-1, binds to the PD, but does not seem
to play a functional role in the packaging process as its binding
ability to the A-repeats does not correlate with the packaging
efficiency. P-complex contains a full-length CDP, which was
identified initially as a cell cycle control factor (Bodmer et al.,
1987; Moon et al., 2000). Interestingly, the full-length CDP was
also found in purified virus particles. A mutation in the TTTG
motif of a critical A-repeat within the PD completely abolished
genome packaging without any effect on the binding of CDP
(Ostapchuk et al., 2005). These observations suggest that CDP
binding is not required for genome packaging.
SEROTYPE SPECIFICITY OF ADV DNA
PACKAGING
Alignment of the PDs of AdV serotypes belonging to different
species revealed the conservation of bipartite consensus motifs of
packaging repeats implying that the packaging of AdV genomes
into non-homologous capsids may be possible (Ostapchuk and
Hearing, 2001). Results of independent studies have indicated
that AdV DNA packaging seems to be serotype-specific (Zhang
et al., 2001; Wohl and Hearing, 2008; Ma and Hearing,
2011). IVa2 and 22K proteins, but not L1 52/55K of HAdV17
serotype are capable of complementing function of the respective
HAdV-C5 proteins, suggesting that 52/55K is important for
serotype specificity of AdV DNA packaging (Wohl and Hearing,
2008). Similarly, an earlier study reported that co-infection
with HAdV7, HAdV12 and HAdV17 cannot complement the
growth of a HAdV-C5 52/55K-null mutant (Zhang et al., 2001).
It seems that the N-terminal 191 amino acids are essential
for imposing serotype-specific function of 52/55K (Wohl and
Hearing, 2008). Since 52/55K does not bind to the A-repeat
consensus independently or in the presence of IVa2, it is possible
that its role in serotype specificity of genome packaging is
mediated by another protein. Interestingly, 52/55K interacts with
the structural protein IIIa from the same AdV serotype and this
interaction is essential for DNA packaging (Ma and Hearing,
2011) suggesting that IIIa and 52/55K act together and their
serotype-specific interaction is the basis for serotype-specific
DNA packaging. Based on the observation that IIIa binds to the
PD in vivo, it is possible that IIIa is the previously unknown factor
that recruits 52/55K to the PD (Ma and Hearing, 2011).
Pre-existing immunity is one of the limitations of AdV-
based vectors in gene delivery applications. Since hexon is the
dominant antigenic determinant of AdV capsids, it is plausible
that packaging of the genome of one serotype into the capsids
of another serotype might help to overcome the pre-existing
immunity hurdle. Co-infection of the HAdV-C5 temperature-
sensitive mutant (Ad5ts147) carrying mutations in the hexon
gene with either HAdV2, HAdV3, HAdV4 or HAdV9 resulted
in “pseudopackaging” of the Ad5ts147 genome into the capsids
of the heterologous serotype and the generation of infectious
virus particles (Ostapchuk and Hearing, 2001). This approach
provides an interesting alternative for circumventing pre-existing
immunity. It will be necessary to block the packaging of the wild-
type genome. A straightforward waymay be to flank the PD of the
wild-type genome with loxP sites so that the PD can be excised by
Cre recombinase.
EVIDENCE FOR SEQUENTIAL ASSEMBLY
OF ADV
Empty Capsids and Intermediates in AdV
Assembly
In viruses that follow the sequential assembly pathways, the
empty capsids, also known as procapsids or proheads, are
essential assembly intermediates. Three components that are
essential for capsid assembly include the coat (major capsid), the
scaffolding and the portal proteins. If AdV follows the sequential
assembly pathway, it must first assemble the empty capsids before
genome packaging, which means that the empty capsids must
be detected during virus infection. Indeed, empty capsids (1.29
g/cm3) can be readily detected in virus-infected cells (Ishibashi
and Maizel, 1974; Edvardsson et al., 1976; Ostapchuk et al.,
2011). Pulse-chase labeling kinetics demonstrated that the empty
capsids are precursors to the mature virions (Sundquist et al.,
1973; Ishibashi and Maizel, 1974). In addition to the empty
capsids that lack any DNA, two classes of assembly intermediates,
called light and heavy, exist in virus-infected cells. The light
assembly intermediates are associated with DNA fragments
derived from the left end of viral genome (Daniell, 1976; Khittoo
and Weber, 1981). Interestingly, the light intermediates range in
density from 1.29 g/cm3 (empty capsids) to 1.34 g/cm3 (mature
virions), with longer DNA fragments associated with the particles
of higher densities (Tibbetts, 1977). The light intermediate
particles possibly represent capsids in which packaging was
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initiated but could not be completed, presumably due to limiting
packaging factors or simply represent capsids that were in the
process of packaging at the time of harvesting of the cells
and the genome was fragmented during virus purification. The
heavy assembly intermediates (1.37 g/cm3) contain DNA with
a sedimentation coefficient similar to that of the viral genome
in the mature virus (D’Halluin et al., 1978a), suggesting that
they represent particles after packaging. Pulse-chase labeling
kinetics demonstrated that light particles are precursors to
heavy particles, which themselves are precursors to the mature
viruses (Weber, 1976; D’Halluin et al., 1978a,b; Edvardsson et al.,
1978), thus suggesting that AdVs follow the sequential assembly
pathway. Khittoo and Weber (1977) analyzed a temperature
sensitive (ts) mutant of HAdV-C2 (ts4) that accumulates light
particles at non-permissive temperature. Interestingly, the light
particles assembled by ts4 mutant at non-permissive temperature
failed to convert to mature viruses even after shift-down to
permissive temperature. Similarly, a ts mutant of HAdV-C5
with a mutation in 52/55K assembled light particles at non-
permissive temperature that failed to convert to mature viruses
at permissive temperature (Hasson et al., 1989). These findings
suggest that the light particles are not bona fide assembly
intermediates, but represent dead-end products. However, it
must be considered that these studies were done with mutant
AdVs. It is possible that once encapsidation is blocked at non-
permissive temperature, it does not restart even after shift-down
to the permissive temperature. In addition, the ts4 mutant of
HAdV-C2 (Khittoo andWeber, 1977) accumulates light particles
in greater amounts than the wild type virus even at permissive
temperature, suggesting that the mutant is not fully functional
at permissive temperature. Several recent reports have shown
that AdVs lacking any one of the functional packaging proteins
(IVa2, 33K or 22K) fail to package the genome, resulting in
accumulation of empty capsids in the mutant virus-infected
cells (Ostapchuk et al., 2011; Wu et al., 2012, 2013; Guimet
and Hearing, 2013). Furthermore, mutation affecting a single
residue in the P-loop motif of IVa2, the packaging ATPase,
also results in accumulation of empty capsids. Thus, either the
absence of any one packaging factor, or a block in the ATPase
function of the packaging ATPase results in accumulation of
empty capsids. Further evidence for the sequential assembly
pathway comes from the helper-dependent (HD) AdV vector
system (Parks et al., 1996). In this system, removal of the PD of
a helper virus is facilitated by cre-mediated excision. Deletion of
the PD from the helper virus genome results in the accumulation
of empty capsids (Stilwell et al., 2003; Ahi et al., 2013). This
observation indicates that the empty capsids are intermediates in
the packaging process.
Scaffolding Proteins
Scaffolding protein-assisted oligomerization of the coat protein
is also seen in AdVs. A characteristic feature of a scaffolding
protein is that it exits the empty capsid and is degraded
after packaging implying its presence in the empty capsids
but not in the mature virions (Dokland, 1999). The 52/55K
protein is present in assembly intermediates, but not in mature
virions (Hasson et al., 1992), suggesting that it might act as a
scaffolding protein. However, empty capsids can be assembled
in absence of the 52/55K, proving that it does not act as a
scaffolding protein (Gustin and Imperiale, 1998). During the late
phase of AdV infection, L4 100K modulates cellular expression
to promote translation of AdV late mRNAs (Hayes et al.,
1990). 100K also acts as a chaperone-like protein and thereby
promotes trimerization of hexon followed by its transport to
the nucleus (Cepko and Sharp, 1982). In addition to these
functions, several observations indicated that 100K may serve
as the scaffolding protein for AdV capsid assembly (Morin
and Boulanger, 1984, 1986). 100K accumulates in the nucleus
during the late stage in virus infection and is present in the
early assembly intermediate particles. There was a lack of capsid
assembly by a temperature-sensitive 100Kmutant (H2ts107), but
it was capable of hexon trimerization and its nuclear transport at
the restrictive temperature. It appears that hexon trimerization
and its nuclear transport functions are mediated by distinct
domains of 100K. Interestingly, the scaffolding function of 100K
seems to be localized in its central domain between amino acids
300–400 (Morin and Boulanger, 1984).
The aforementioned observations only provide a limited
insight into the scaffolding function of AdV. The following
questions are still unanswered: Where and how does the capsid
assembly occur? Does a portal or a similar structure serve as a
nucleation point for capsid assembly? How many copies of L4
100K are present in the assembly intermediates or what is the
optimal ratio of hexon trimer to 100K for efficient assembly?
How and when does 100K exit the capsids after assembly, or is it
degraded by AdV protease or by another mechanism? Cleavage
by viral protease is required for the transport of BAdV3 100K
protein to the nucleus, but a similar observation is not reported
for other AdVs (Makadiya et al., 2015). Interestingly, 100K of
HAdV-C5 is cleaved by a host cell-encoded serine protease and
GranzymeB into 70, 80 and 95 kDa fragments (Andrade et al.,
2007). A 90 kDa cleavage product of 100K is also detected in
vast amounts in H2ts107 assembly intermediates (Morin and
Boulanger, 1986); however, it is not yet clear if these cleavage
products are related. The 90kDa species detected in H2ts107
assembly intermediates could have a differential role in assembly
than the full-length 100K since 90kDa forms a complex with the
groups of nine hexons, whereas the full-length 100K seems to be
associated with IIIa and penton base located at vertices (Morin
and Boulanger, 1986).
DNA Encapsidating Motor Complex
In viruses known to use the sequential packaging pathway, the
portal serves as a site for assembly of the DNA packaging motor.
The minimal, essential components of the packaging motor in
known viruses include an enzyme with ATPase activity, known as
“large terminase” or “packaging ATPase,” and a protein that helps
in DNA recognition and potentiates ATPase activity, known
as the “small terminase.” The ATPase activity is essential for
pushing the DNA into a relatively small volume inside the capsid
(Chelikani et al., 2014). The function of IVa2 in AdV packaging
is presumably comparable to that of the packaging ATPases. We
have demonstrated that purified L4 33K protein stimulates the
ATPase activity of IVa2 (Ahi et al., 2015). This result suggests
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that 33K is equivalent to a small terminase protein; however
further characterization of this function of 33K is necessary. It is
possible that the genome packaging step in AdVs involves more
components than those mentioned above. Also, both 22K and
33K seem to be essential for the genome packaging step, and the
absence of either one results in accumulation of empty capsids
(Wu et al., 2012, 2013; Guimet and Hearing, 2013). Therefore, it
is possible that both proteins function cooperatively.
Similarities between AdV and Phage PRD1
Remarkable structural similarities between AdVs and
bacteriophage PRD1 have been observed (Krupovic and
Bamford, 2008). AdVs and PRD1 share the following features: a
linear dsDNA genome with ITRs of similar size and a covalently
attached terminal protein; protein-primed replication of the viral
genome; capsids with a pseudo T = 25 lattice; trimeric major
capsid proteins (MCP) with a double beta barrel fold that gives
rise to a pseudohexagonal arrangement of the MCP (Benson
et al., 2004); vertices occupied by pentameric proteins that are
associated with a spike protein or a fiber; and the presence of
a virion-associated packaging ATPase-like protein (Stromsten
et al., 2005; Huiskonen et al., 2007).
The PRD1 genome is packaged into preformed capsids
through a DNA packaging complex located at a unique vertex
(Hong et al., 2014). Because of the striking parallels between
AdVs and PRD1, it is likely that the genome packaging in
AdV follows a pathway similar to PRD1. Genome packaging
in PRD1 is assisted by the virion-associated packaging ATPase,
protein P9 (Stromsten et al., 2005). It is interesting to note
that IVa2, the AdV equivalent of the packaging ATPases, is also
a virion-associated protein. Four virus-encoded proteins, P6,
P9, P20 and P22, constitute the unique vertex of PRD1 (Hong
et al., 2014). One notable feature of PRD1 is the presence of
an internal membrane. The proteins P20 and P22 constitute the
transmembrane conduit for the passage of the genome during
packaging, whereas P6 acts as a packaging efficiency factor, which
assists the packaging ATPase P9 (Stromsten et al., 2005; Hong
et al., 2014). Although existence of a unique vertex in AdV has
been reported, the components of the AdV unique vertex have
not been fully determined; however, the presence of IVa2, 33K
and DBP on a single location (Ahi et al., 2013) on the viral
capsid suggest that they likely constitute the AdV unique vertex.
Although AdV shares several features with PRD1, they do not
have a similar membrane component as seen in PRD1, suggesting
that the mechanistic details of the AdV packaging process may
differ from that of PRD1.
CONCLUDING REMARKS
Extensive characterization of the cis-acting PD sequences of
the AdV genome has led to the identification of several trans-
acting factors that bind to the PD and are important for
genome packaging. Localization of IVa2, 33K and DBP on a
unique vertex provided strong evidence that the AdV likely
harbors a structure equivalent to the portal complex observed
in dsDNA bacteriophages and herpesviruses. Additionally, the
accumulation of empty capsids in the absence of a functional
IVa2, 22K, 33K or 52/55K strongly suggest that AdV follows
a sequential assembly pathway. It is not clear how and when
each of these proteins participates during genome packaging,
and thus further exploration is necessary to precisely dissect
their roles. Taking into consideration the advancement in the
understanding of capsid assembly and genome packaging in
dsDNA bacteriophages, the knowledge of AdV assembly and
packaging is still in its infancy. AdV being a mammalian virus,
it will not be surprising if its packaging system differs from
that observed in bacteriophages. Characterization of the AdV
portal by virological, biochemical and structural studies will
be critical for defining the structural and functional aspects of
the AdV packaging motor complex. Study of each component
of the AdV packaging process by advanced structural biology
techniques (such as cryo-electron tomography and atomic
force microscopy) will illustrate their structural features and
the domains that are involved in homo-oligomerization and
that participate in interactions with other components of the
packaging complex. Understanding of AdV packaging process
will elucidate the necessary components and conditions for
developing an in vitro packaging system for AdV, which will
help in generating next generation of AdV vectors with better
cell targeting and vaccine immunogenicity, but reduced vector
immunity.
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